Cargando…
A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia
With improved contemporary therapy, we re-assess long-term outcome in patients completing treatment for childhood acute lymphoblastic leukemia to determine when cure can be declared with a high degree of confidence. In 6 successive clinical trials between 1984 and 2007, 1291(84.5%) patients complete...
Autores principales: | Pui, CH, Pei, D, Campana, D, Cheng, C, Sandlund, JT, Bowman, WP, Hudson, MM, Ribeiro, RC, Raimondi, SC, Jeha, S, Howard, SC, Bhojwani, D, Inaba, H, Rubnitz, JE, Metzger, ML, Gruber, TA, Coustan-Smith, E, Downing, JR, Leung, WH, Relling, MV, Evans, WE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214904/ https://www.ncbi.nlm.nih.gov/pubmed/24781017 http://dx.doi.org/10.1038/leu.2014.142 |
Ejemplares similares
-
Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
por: Pui, C-H, et al.
Publicado: (2009) -
Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy
por: Pui, Ching-Hon, et al.
Publicado: (2016) -
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
por: Gruber, Tanja A., et al.
Publicado: (2022) -
Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments
por: Pauley, Jennifer L., et al.
Publicado: (2013) -
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments
por: Pauley, Jennifer L., et al.
Publicado: (2013)